Christopher J. Kane, MD, is a board-certified urologic oncologist. He has a special interest in treating patients with prostate cancer and has extensive expertise in robotic prostatectomy, open and laparoscopic kidney cancer surgery, and bladder and testes cancer surgery. Dr. Kane performs over 200 robotic cancer surgeries per year and is highly experienced in nerve sparing robotic prostatectomies, robotic radical cystectomy for bladder cancer, and robotic partial nephrectomy for kidney cancer. He is internationally recognized for patient care and research in prostate cancer, renal cell carcinoma, robotic and minimally invasive surgical treatment of urologic diseases and disorders, and risk stratification and outcomes after treatment. Dr. Kane has authored more than 240 peer-reviewed research articles with a focus on prostate cancer risk factors and outcomes, prostate cancer surgery and minimally invasive surgery for prostate and kidney cancer. He serves on the editorial boards of several major urology journals as well as the National Comprehensive Cancer Network (NCCN) Prostate Cancer Management Guidelines Committee. He also co-chairs the National Cancer Institute’s Renal Cell Carcinoma Advisory Task Force. Prior to joining UC San Diego Health, Dr. Kane held leadership positions at UC San Francisco and the Naval Medical Center San Diego. He was awarded the Distinguished Engineering Alumni Medal by UC Davis in 2011. In 2014 he was elected to membership in the American Association of Genitourinary Surgeons. He is a retired Navy Captain and a decorated veteran of Desert Storm. Dr. Kane completed his residency at the Naval Medical Center in Oakland, California. He received his medical degree from Uniformed Services University of the Health Sciences in Bethesda, Maryland. Dr. Kane is board-certified in urology.